- Home
- Schoemaker Kathleen K
Insider Trading History of Schoemaker Kathleen K
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Schoemaker Kathleen K since 2006.
The trader's CIK number is 1207789.
At the time of the last reporting, Schoemaker Kathleen K was the 10% Owner of Glaukos Corp. (stock ticker symbol GKOS).
Also see all insider trading activities at Glaukos Corp.
Note that in the past
SCHOEMAKER KATHLEEN K also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Esperion Therapeutics, Inc. (ESPR) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ESPR | 285,714 | $3,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (NOVC) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | NOVC | 0 | $0 | 250,000 | $238,755 | 0 | $0 |
| 2007 | NOVC | 0 | $0 | 24,500 | $275,870 | 0 | $0 |
| 2006 | NOVC | 461,538 | $2,999,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | SOMX | 0 | $0 | 12,918 | $171,485 | 0 | $0 |
Yearly summary of insider trading at Volcano Corp (VOLC) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | VOLC | 0 | $0 | 36,189 | $498,961 | 0 | $0 |
| 2007 | VOLC | 0 | $0 | 25,247 | $486,004 | 0 | $0 |
| 2006 | VOLC | 0 | $0 | 1,508,249 | $25,263,170 | 0 | $0 |
Yearly summary of insider trading at Durata Therapeutics, Inc. (DRTX) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | DRTX | 784,313 | $7,058,817 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alimera Sciences Inc (ALIM) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ALIM | 0 | $0 | 300,000 | $1,916,598 | 0 | $0 |
| 2013 | ALIM | 0 | $0 | 244,725 | $1,264,367 | 0 | $0 |
| 2011 | ALIM | 0 | $0 | 6,914 | $55,588 | 0 | $0 |
| 2010 | ALIM | 378,028 | $4,158,308 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Clovis Oncology, Inc. (CLVS) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | CLVS | 0 | $0 | 416,171 | $16,711,981 | 0 | $0 |
| 2011 | CLVS | 931,683 | $12,111,879 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regado Biosciences Inc (RGDO) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | RGDO | 750,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Glaukos Corp (GKOS) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | GKOS | 0 | $0 | 0 | $0 | 20,470 | $156,595 |
Yearly summary of insider trading at Cadence Pharmaceuticals Inc (CADX) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CADX | 0 | $0 | 0 | $0 | 1,390,337 | $10,900,241 |
| 2013 | CADX | 0 | $0 | 1,499,000 | $8,058,322 | 0 | $0 |
| 2009 | CADX | 2,780,674 | $19,826,205 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | ZGNX | 3,500,000 | $7,000,000 | 0 | $0 | 0 | $0 |
| 2010 | ZGNX | 2,349,999 | $9,399,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Reva Medical, Inc. (RVA) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | RVA | 0 | $0 | 1,695,717 | $8,749,899 | 0 | $0 |
Yearly summary of insider trading at Orexigen Therapeutics, Inc. (OREX) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | OREX | 469,147 | $680,263 | 0 | $0 | 0 | $0 |
| 2009 | OREX | 2,058,610 | $15,303,325 | 0 | $0 | 0 | $0 |
| 2008 | OREX | 490,301 | $2,302,914 | 0 | $0 | 0 | $0 |
| 2007 | OREX | 525,000 | $6,300,000 | 21,000 | $299,670 | 0 | $0 |
Yearly summary of insider trading at Vanda Pharmaceuticals Inc. (VNDA) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | VNDA | 0 | $0 | 12,900 | $330,498 | 0 | $0 |
Yearly summary of insider trading at Tranzyme Inc (OCRX) by Schoemaker Kathleen K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | OCRX | 1,327,491 | $7,999,460 | 0 | $0 | 0 | $0 |
Insider trading activities at 15 companies by Schoemaker Kathleen K:
1. Esperion Therapeutics, Inc. (ESPR)
2. Paratek Pharmaceuticals, Inc. (NOVC)
3. Somaxon Pharmaceuticals, Inc. (SOMX)
4. Volcano Corp (VOLC)
5. Durata Therapeutics, Inc. (DRTX)
6. Alimera Sciences Inc (ALIM)
7. Clovis Oncology, Inc. (CLVS)
8. Regado Biosciences Inc (RGDO)
9. Glaukos Corp (GKOS)
10. Cadence Pharmaceuticals Inc (CADX)
11. Zogenix, Inc. (ZGNX)
12. Reva Medical, Inc. (RVA)
13. Orexigen Therapeutics, Inc. (OREX)
14. Vanda Pharmaceuticals Inc. (VNDA)
15. Tranzyme Inc (OCRX)
Table 1. Insider trading of Esperion Therapeutics, Inc. (ESPR) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-01 | ESPR | Buy | 285,714 | 14.00 | 3,999,996 |
Table 2. Insider trading of Paratek Pharmaceuticals, Inc. (NOVC) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-01-30 | NOVC | Sale | 150,300 | .98 | 147,294 |
| 2009-01-29 | NOVC | Sale | 63,000 | .91 | 57,330 |
| 2009-01-28 | NOVC | Sale | 36,700 | .93 | 34,131 |
| 2007-06-06 | NOVC | Sale | 24,500 | 11.26 | 275,870 |
| 2006-05-15 | NOVC | Buy | 461,538 | 6.50 | 2,999,997 |
Table 3. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-12-21 | SOMX | Sale | 6,459 | 13.52 | 87,325 |
| 2006-09-18 | SOMX | Sale | 6,459 | 13.03 | 84,160 |
Table 4. Insider trading of Volcano Corp (VOLC) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-07-16 | VOLC | Sale | 19,357 | 14.49 | 280,482 |
| 2008-04-08 | VOLC | Sale | 16,832 | 12.98 | 218,479 |
| 2007-05-18 | VOLC | Sale | 25,247 | 19.25 | 486,004 |
| 2006-12-06 | VOLC | Sale | 1,508,249 | 16.75 | 25,263,170 |
Table 5. Insider trading of Durata Therapeutics, Inc. (DRTX) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-07-24 | DRTX | Buy | 784,313 | 9.00 | 7,058,817 |
Table 6. Insider trading of Alimera Sciences Inc (ALIM) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-01-16 | ALIM | Sale | 204,315 | 6.56 | 1,340,306 |
| 2014-01-15 | ALIM | Sale | 1,010 | 6.01 | 6,070 |
| 2014-01-16 | ALIM | Sale | 2,230 | 6.56 | 14,628 |
| 2014-01-15 | ALIM | Sale | 92,445 | 6.01 | 555,594 |
| 2013-06-20 | ALIM | Sale | 10,516 | 5.01 | 52,685 |
| 2013-06-20 | ALIM | Sale | 114 | 5.01 | 571 |
| 2013-06-19 | ALIM | Sale | 244 | 5.37 | 1,310 |
| 2013-06-18 | ALIM | Sale | 359 | 5.40 | 1,938 |
| 2013-06-19 | ALIM | Sale | 22,423 | 5.37 | 120,411 |
| 2013-06-18 | ALIM | Sale | 32,855 | 5.40 | 177,417 |
| 2013-06-14 | ALIM | Sale | 38,897 | 5.03 | 195,651 |
| 2013-06-17 | ALIM | Sale | 87,812 | 5.40 | 474,184 |
| 2013-06-14 | ALIM | Sale | 425 | 5.03 | 2,137 |
| 2013-06-17 | ALIM | Sale | 959 | 5.40 | 5,178 |
| 2013-06-11 | ALIM | Sale | 5,337 | 5.00 | 26,685 |
| 2013-06-11 | ALIM | Sale | 59 | 5.00 | 295 |
| 2013-05-16 | ALIM | Sale | 232 | 4.50 | 1,044 |
| 2013-05-15 | ALIM | Sale | 251 | 4.70 | 1,179 |
| 2013-05-16 | ALIM | Sale | 21,276 | 4.50 | 95,742 |
| 2013-05-15 | ALIM | Sale | 22,966 | 4.70 | 107,940 |
| 2011-06-02 | ALIM | Sale | 6,914 | 8.04 | 55,588 |
| 2010-04-27 | ALIM | Buy | 378,028 | 11.00 | 4,158,308 |
Table 7. Insider trading of Clovis Oncology, Inc. (CLVS) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-06-04 | CLVS | Sale | 2,779 | 64.58 | 179,467 |
| 2013-06-04 | CLVS | Sale | 159,192 | 64.58 | 10,280,619 |
| 2013-03-05 | CLVS | Sale | 2,132 | 24.69 | 52,639 |
| 2013-03-04 | CLVS | Sale | 417 | 24.44 | 10,191 |
| 2013-03-06 | CLVS | Sale | 1,651 | 24.51 | 40,466 |
| 2013-03-05 | CLVS | Sale | 126,868 | 24.69 | 3,132,370 |
| 2013-03-04 | CLVS | Sale | 24,783 | 24.44 | 605,696 |
| 2013-03-06 | CLVS | Sale | 98,349 | 24.51 | 2,410,533 |
| 2011-11-21 | CLVS | Buy | 931,683 | 13.00 | 12,111,879 |
Table 8. Insider trading of Regado Biosciences Inc (RGDO) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-08-27 | RGDO | Buy | 750,000 | 4.00 | 3,000,000 |
Table 9. Insider trading of Glaukos Corp (GKOS) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-30 | GKOS | Option Ex | 20,470 | 7.65 | 156,595 |
Table 10. Insider trading of Cadence Pharmaceuticals Inc (CADX) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-12 | CADX | Option Ex | 1,367,020 | 7.84 | 10,717,436 |
| 2014-02-12 | CADX | Option Ex | 23,317 | 7.84 | 182,805 |
| 2013-04-15 | CADX | Sale | 23,210 | 6.62 | 153,650 |
| 2013-04-15 | CADX | Sale | 71,578 | 6.62 | 473,846 |
| 2013-04-10 | CADX | Sale | 1,567 | 6.72 | 10,530 |
| 2013-04-09 | CADX | Sale | 11,386 | 6.71 | 76,400 |
| 2013-04-08 | CADX | Sale | 12,217 | 6.52 | 79,654 |
| 2013-04-10 | CADX | Sale | 4,832 | 6.72 | 32,471 |
| 2013-04-09 | CADX | Sale | 35,114 | 6.71 | 235,614 |
| 2013-04-08 | CADX | Sale | 37,676 | 6.52 | 245,647 |
| 2013-03-21 | CADX | Sale | 1,743 | 5.49 | 9,569 |
| 2013-03-21 | CADX | Sale | 893 | 5.49 | 4,902 |
| 2013-03-21 | CADX | Sale | 4,374 | 5.35 | 23,400 |
| 2013-03-21 | CADX | Sale | 13,490 | 5.35 | 72,171 |
| 2013-03-20 | CADX | Sale | 5,510 | 5.22 | 28,762 |
| 2013-03-19 | CADX | Sale | 7,925 | 5.19 | 41,130 |
| 2013-03-20 | CADX | Sale | 92 | 5.22 | 480 |
| 2013-03-19 | CADX | Sale | 134 | 5.19 | 695 |
| 2013-03-20 | CADX | Sale | 16,995 | 5.22 | 88,713 |
| 2013-03-19 | CADX | Sale | 24,442 | 5.19 | 126,853 |
| 2013-03-20 | CADX | Sale | 182 | 5.22 | 950 |
| 2013-03-19 | CADX | Sale | 261 | 5.19 | 1,354 |
| 2013-03-18 | CADX | Sale | 24,736 | 5.16 | 127,637 |
| 2013-03-15 | CADX | Sale | 9,636 | 5.28 | 50,878 |
| 2013-03-15 | CADX | Sale | 29,719 | 5.28 | 156,916 |
| 2013-03-18 | CADX | Sale | 8,020 | 5.16 | 41,383 |
| 2013-03-15 | CADX | Sale | 318 | 5.28 | 1,679 |
| 2013-03-15 | CADX | Sale | 163 | 5.28 | 860 |
| 2013-03-18 | CADX | Sale | 135 | 5.16 | 696 |
| 2013-03-18 | CADX | Sale | 265 | 5.16 | 1,367 |
| 2013-03-14 | CADX | Sale | 166 | 5.36 | 889 |
| 2013-03-13 | CADX | Sale | 256 | 5.40 | 1,382 |
| 2013-03-14 | CADX | Sale | 85 | 5.36 | 455 |
| 2013-03-13 | CADX | Sale | 131 | 5.40 | 707 |
| 2013-03-14 | CADX | Sale | 15,480 | 5.36 | 82,972 |
| 2013-03-13 | CADX | Sale | 23,848 | 5.40 | 128,779 |
| 2013-03-14 | CADX | Sale | 5,020 | 5.36 | 26,907 |
| 2013-03-13 | CADX | Sale | 7,733 | 5.40 | 41,758 |
| 2013-03-12 | CADX | Sale | 210 | 5.38 | 1,129 |
| 2013-03-11 | CADX | Sale | 136 | 5.34 | 726 |
| 2013-03-12 | CADX | Sale | 107 | 5.38 | 575 |
| 2013-03-11 | CADX | Sale | 70 | 5.34 | 373 |
| 2013-03-12 | CADX | Sale | 19,569 | 5.38 | 105,281 |
| 2013-03-11 | CADX | Sale | 12,700 | 5.34 | 67,818 |
| 2013-03-12 | CADX | Sale | 6,346 | 5.38 | 34,141 |
| 2013-03-11 | CADX | Sale | 4,118 | 5.34 | 21,990 |
| 2013-03-08 | CADX | Sale | 5,154 | 5.32 | 27,419 |
| 2013-03-08 | CADX | Sale | 171 | 5.32 | 909 |
| 2013-03-07 | CADX | Sale | 12,701 | 5.22 | 66,299 |
| 2013-03-07 | CADX | Sale | 420 | 5.22 | 2,192 |
| 2013-03-08 | CADX | Sale | 88 | 5.32 | 468 |
| 2013-03-07 | CADX | Sale | 215 | 5.22 | 1,122 |
| 2013-03-08 | CADX | Sale | 15,892 | 5.32 | 84,545 |
| 2013-03-07 | CADX | Sale | 39,168 | 5.22 | 204,456 |
| 2013-03-05 | CADX | Sale | 4,039 | 5.01 | 20,235 |
| 2013-03-06 | CADX | Sale | 3,839 | 5.06 | 19,425 |
| 2013-03-05 | CADX | Sale | 134 | 5.01 | 671 |
| 2013-03-06 | CADX | Sale | 127 | 5.06 | 642 |
| 2013-03-05 | CADX | Sale | 69 | 5.01 | 345 |
| 2013-03-06 | CADX | Sale | 65 | 5.06 | 328 |
| 2013-03-05 | CADX | Sale | 12,454 | 5.01 | 62,394 |
| 2013-03-06 | CADX | Sale | 11,841 | 5.06 | 59,915 |
| 2013-03-04 | CADX | Sale | 5,145 | 5.01 | 25,776 |
| 2013-03-01 | CADX | Sale | 7,635 | 5.01 | 38,251 |
| 2013-03-04 | CADX | Sale | 15,865 | 5.01 | 79,483 |
| 2013-03-01 | CADX | Sale | 23,548 | 5.01 | 117,975 |
| 2013-03-04 | CADX | Sale | 88 | 5.01 | 440 |
| 2013-03-01 | CADX | Sale | 130 | 5.01 | 651 |
| 2013-03-04 | CADX | Sale | 170 | 5.01 | 851 |
| 2013-03-01 | CADX | Sale | 253 | 5.01 | 1,267 |
| 2013-02-20 | CADX | Sale | 6,160 | 5.01 | 30,861 |
| 2013-02-20 | CADX | Sale | 66 | 5.01 | 330 |
| 2013-02-20 | CADX | Sale | 34 | 5.01 | 170 |
| 2013-02-20 | CADX | Sale | 1,998 | 5.01 | 10,009 |
| 2013-02-19 | CADX | Sale | 334 | 5.02 | 1,676 |
| 2013-02-15 | CADX | Sale | 99 | 5.00 | 495 |
| 2013-02-19 | CADX | Sale | 31,075 | 5.02 | 155,996 |
| 2013-02-15 | CADX | Sale | 9,148 | 5.00 | 45,740 |
| 2013-02-19 | CADX | Sale | 171 | 5.02 | 858 |
| 2013-02-15 | CADX | Sale | 51 | 5.00 | 255 |
| 2013-02-19 | CADX | Sale | 10,076 | 5.02 | 50,581 |
| 2013-02-15 | CADX | Sale | 2,967 | 5.00 | 14,835 |
| 2013-02-14 | CADX | Sale | 9,100 | 5.01 | 45,591 |
| 2013-02-13 | CADX | Sale | 17,770 | 5.00 | 88,850 |
| 2013-02-14 | CADX | Sale | 98 | 5.01 | 490 |
| 2013-02-13 | CADX | Sale | 191 | 5.00 | 955 |
| 2013-02-14 | CADX | Sale | 2,951 | 5.01 | 14,784 |
| 2013-02-13 | CADX | Sale | 5,763 | 5.00 | 28,815 |
| 2013-02-14 | CADX | Sale | 51 | 5.01 | 255 |
| 2013-02-13 | CADX | Sale | 98 | 5.00 | 490 |
| 2013-02-01 | CADX | Sale | 30,134 | 4.85 | 146,149 |
| 2013-02-01 | CADX | Sale | 164 | 4.85 | 795 |
| 2013-02-01 | CADX | Sale | 322 | 4.85 | 1,561 |
| 2013-02-01 | CADX | Sale | 9,769 | 4.85 | 47,379 |
| 2013-01-31 | CADX | Sale | 314 | 4.71 | 1,478 |
| 2013-01-30 | CADX | Sale | 188 | 5.00 | 940 |
| 2013-01-31 | CADX | Sale | 57,165 | 4.71 | 269,247 |
| 2013-01-30 | CADX | Sale | 34,248 | 5.00 | 171,240 |
| 2013-01-31 | CADX | Sale | 18,537 | 4.71 | 87,309 |
| 2013-01-31 | CADX | Sale | 613 | 4.71 | 2,887 |
| 2013-01-30 | CADX | Sale | 11,105 | 5.00 | 55,525 |
| 2013-01-30 | CADX | Sale | 367 | 5.00 | 1,835 |
| 2013-01-29 | CADX | Sale | 15,320 | 5.27 | 80,736 |
| 2013-01-28 | CADX | Sale | 16,660 | 5.40 | 89,964 |
| 2013-01-29 | CADX | Sale | 260 | 5.27 | 1,370 |
| 2013-01-28 | CADX | Sale | 282 | 5.40 | 1,522 |
| 2013-01-29 | CADX | Sale | 507 | 5.27 | 2,671 |
| 2013-01-28 | CADX | Sale | 551 | 5.40 | 2,975 |
| 2013-01-29 | CADX | Sale | 47,247 | 5.27 | 248,991 |
| 2013-01-28 | CADX | Sale | 51,377 | 5.40 | 277,435 |
| 2013-01-24 | CADX | Sale | 36,324 | 5.45 | 197,965 |
| 2013-01-25 | CADX | Sale | 13,790 | 5.38 | 74,190 |
| 2013-01-24 | CADX | Sale | 111,022 | 5.45 | 605,069 |
| 2013-01-25 | CADX | Sale | 42,525 | 5.38 | 228,784 |
| 2013-01-24 | CADX | Sale | 616 | 5.45 | 3,357 |
| 2013-01-25 | CADX | Sale | 234 | 5.38 | 1,258 |
| 2013-01-24 | CADX | Sale | 1,201 | 5.45 | 6,545 |
| 2013-01-25 | CADX | Sale | 456 | 5.38 | 2,453 |
| 2013-01-23 | CADX | Sale | 78,188 | 5.11 | 399,540 |
| 2013-01-23 | CADX | Sale | 25,354 | 5.11 | 129,558 |
| 2013-01-22 | CADX | Sale | 14,966 | 5.02 | 75,129 |
| 2013-01-22 | CADX | Sale | 46,153 | 5.02 | 231,688 |
| 2013-01-23 | CADX | Sale | 430 | 5.11 | 2,197 |
| 2013-01-22 | CADX | Sale | 495 | 5.02 | 2,484 |
| 2013-01-23 | CADX | Sale | 839 | 5.11 | 4,287 |
| 2013-01-22 | CADX | Sale | 254 | 5.02 | 1,275 |
| 2013-01-18 | CADX | Sale | 324 | 5.19 | 1,681 |
| 2013-01-17 | CADX | Sale | 214 | 5.35 | 1,144 |
| 2013-01-18 | CADX | Sale | 58,838 | 5.19 | 305,369 |
| 2013-01-17 | CADX | Sale | 38,903 | 5.35 | 208,131 |
| 2013-01-18 | CADX | Sale | 19,080 | 5.19 | 99,025 |
| 2013-01-17 | CADX | Sale | 12,615 | 5.35 | 67,490 |
| 2013-01-18 | CADX | Sale | 631 | 5.19 | 3,274 |
| 2013-01-17 | CADX | Sale | 418 | 5.35 | 2,236 |
| 2009-02-18 | CADX | Buy | 2,780,674 | 7.13 | 19,826,205 |
Table 11. Insider trading of Zogenix, Inc. (ZGNX) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-16 | ZGNX | Buy | 3,500,000 | 2.00 | 7,000,000 |
| 2010-11-29 | ZGNX | Buy | 2,349,999 | 4.00 | 9,399,996 |
Table 12. Insider trading of Reva Medical, Inc. (RVA) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-23 | RVA | Sale | 1,695,717 | 5.16 | 8,749,899 |
Table 13. Insider trading of Orexigen Therapeutics, Inc. (OREX) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-12-22 | OREX | Buy | 469,147 | 1.45 | 680,263 |
| 2009-12-18 | OREX | Buy | 38,100 | 7.50 | 285,750 |
| 2009-12-17 | OREX | Buy | 100,000 | 7.55 | 755,000 |
| 2009-11-24 | OREX | Buy | 50,000 | 6.75 | 337,500 |
| 2009-11-20 | OREX | Buy | 250,000 | 6.93 | 1,732,500 |
| 2009-11-23 | OREX | Buy | 150,000 | 6.93 | 1,039,500 |
| 2009-11-12 | OREX | Buy | 62,000 | 6.90 | 427,800 |
| 2009-11-11 | OREX | Buy | 53,600 | 6.93 | 371,448 |
| 2009-11-10 | OREX | Buy | 84,400 | 6.93 | 584,892 |
| 2009-08-18 | OREX | Buy | 13,784 | 7.73 | 106,550 |
| 2009-08-14 | OREX | Buy | 26,225 | 8.00 | 209,800 |
| 2009-08-17 | OREX | Buy | 63,201 | 7.64 | 482,855 |
| 2009-08-13 | OREX | Buy | 13,000 | 7.85 | 102,050 |
| 2009-08-12 | OREX | Buy | 400,000 | 8.00 | 3,200,000 |
| 2009-08-11 | OREX | Buy | 104,300 | 7.60 | 792,680 |
| 2009-07-23 | OREX | Buy | 650,000 | 7.50 | 4,875,000 |
| 2008-12-08 | OREX | Buy | 248,411 | 4.47 | 1,110,397 |
| 2008-12-09 | OREX | Buy | 241,890 | 4.93 | 1,192,517 |
| 2007-11-27 | OREX | Sale | 21,000 | 14.27 | 299,670 |
| 2007-05-01 | OREX | Buy | 525,000 | 12.00 | 6,300,000 |
Table 14. Insider trading of Vanda Pharmaceuticals Inc. (VNDA) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-12-12 | VNDA | Sale | 12,900 | 25.62 | 330,498 |
Table 15. Insider trading of Tranzyme Inc (OCRX) by Schoemaker Kathleen K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-15 | OCRX | Buy | 1,327,491 | 6.03 | 7,999,460 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schoemaker Kathleen K
(10% Owner of Glaukos Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.